Proposed Data Collections Submitted for Public Comment and Recommendations, 67147-67148 [2013-26787]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 217 / Friday, November 8, 2013 / Notices
of the Board of Governors. Comments
must be received not later than
November 26, 2013.
A. Federal Reserve Bank of Atlanta
(Chapelle Davis, Assistant Vice
President) 1000 Peachtree Street NE.,
Atlanta, Georgia 30309:
1. Ben F. Easterlin, IV, and Tommye
B. Easterlin, both of Atlanta, Georgia; to
retain voting shares of CBA Bankshares,
Inc., and thereby indirectly retain voting
shares of Citizens Bank of Americus,
both in Americus, Georgia.
B. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. George W. Cummings, III; Nanette
Weaver Cummings; George W.
Cummings, Jr.; Dewey F. Weaver Jr.;
Colby Weaver, all of Monroe, Louisiana;
Twist Family, LLP; Randall Twist, both
of Dallas, Texas; and Dewey Weaver, III,
West Monroe, Louisiana; to retain
voting shares of Progressive Bancorp,
Inc., and thereby indirectly retain voting
shares of Progressive Bank, both in
Monroe, Louisiana.
Board of Governors of the Federal Reserve
System, November 5, 2013.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2013–26819 Filed 11–7–13; 8:45 am]
BILLING CODE 6210–01–P
TKELLEY on DSK3SPTVN1PROD with NOTICES
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
18:08 Nov 07, 2013
Board of Governors of the Federal Reserve
System, November 5, 2013.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2013–26818 Filed 11–7–13; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RETIREMENT THRIFT
INVESTMENT BOARD
Senior Executive Service Performance
Review Board
Federal Retirement Thrift
Investment Board.
AGENCY:
ACTION:
Notice.
This notice announces the
appointment of the members of the
Senior Executive Service Performance
Review Boards for the Federal
Retirement Thrift Investment Board.
The purpose of the Performance Review
Boards is to view and make
recommendations concerning proposed
performance appraisals, ratings, and
bonuses, and other appropriate
personnel actions for members of the
Senior Executive Service.
SUMMARY:
FEDERAL RESERVE SYSTEM
VerDate Mar<15>2010
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than November 26, 2013.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Central Texas Financial Corp.,
Cameron, Texas; to engage de novo in
lending activities, pursuant to section
225.28(b)(1).
Jkt 232001
This notice is effective
November 5, 2013.
DATES:
FOR FURTHER INFORMATION CONTACT:
Kelly Powell, HR Specialist, at 202–
942–1681.
Title 5,
U.S. Code, 4314(c)(4), requires that the
appointment of Performance Review
Board members be published in the
Federal Register before Board service
commences. The following persons will
serve on the Federal Retirement Thrift
Investment Board’s Performance Review
Boards which will oversee the
evaluation of the performance
appraisals of the Senior Executive
Service members of the Federal
Retirement Thrift Investment Board:
Tracey A. Ray, Kimberly Weaver, Mark
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
67147
Walther, Jayant Ahuja, Susan Crowder
and Gisile Goethe.
James B. Petrick,
General Counsel, Federal Retirement Thrift
Investment Board.
[FR Doc. 2013–26808 Filed 11–7–13; 8:45 am]
BILLING CODE 6760–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60–Day–14–0888]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Kimberly Lane, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Persistence of Viable Influenza Virus
in Aerosols (0920–0888, Expiration 05/
31/2014)—Revision—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The National Institute for
Occupational Safety and Health
(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a)(1)
E:\FR\FM\08NON1.SGM
08NON1
67148
Federal Register / Vol. 78, No. 217 / Friday, November 8, 2013 / Notices
of the 1970 Occupational Safety and
Health Act. Influenza continues to be a
major public health concern because of
the substantial health burden from
seasonal influenza and the potential for
a severe pandemic. Although influenza
is known to be transmitted by infectious
secretions, these secretions can be
transferred from person to person in
many different ways, and the relative
importance of the different pathways is
not known. The likelihood of the
transmission of influenza virus by small
infectious airborne particles produced
during coughing and breathing is
particularly unclear. The question of
airborne transmission is especially
important in healthcare facilities, where
influenza patients tend to congregate
during influenza season, because it
directly impacts the infection control
and personal protective measures that
should be taken by healthcare workers.
The purpose of this study is to measure
the amount of viable influenza virus in
airborne particles that are produced by
patients when they cough, and the size
and quantity of the particles carrying
the virus. A better understanding of the
amount of potentially infectious
material released by patients and the
size of the particles carrying the virus
will assist in determining the possible
role of airborne transmission in the
spread of influenza and in devising
measures to prevent it.
132 to 360. In a previous similar study,
the number of potential participants
who agree to join the study was 50%,
which was lower than anticipated. The
increase will allow the study to recruit
180 participants.
(3) The number of qualified
participants has been increased from
120 to 180. This is necessary to provide
a sufficient number of cough aerosol
samples with detectable amounts of
viable influenza and is based on a
previous study, where 10% of aerosol
samples had culturable virus.
(4) The Informed consent form has
been substantially revised to make it
easier to read and understand. As a
result of the revisions, the burden per
response for that form has been reduced
from 20 to 15 minutes.
(5) Because of the increases in the
number of potential and qualified
participants, the total burden hours has
increased from 51 to 78 hours.
(6) The title of the ICR has been
changed to ‘‘Factors Influencing the
Transmission of Influenza’’ in order to
reflect the new focus of the project on
influenza viability and to match the title
of the human subjects protocol
approved by the Institutional Review
Board.
There are no costs to respondents
other than their time.
Volunteer adult participants will be
recruited by a test coordinator using a
poster and flyers describing the study.
Interested potential participants will be
screened verbally to verify that they
have influenza-like symptoms and that
they do not have any medical
conditions that would preclude their
participation. Qualified participants
who agree to participate in the study
will be asked to read and sign an
informed consent form, and then to
complete a short health questionnaire.
After completing the forms, two
nasopharyngeal swabs and one
oropharyngeal swab will be collected
from the participant. They then will be
asked to cough repeatedly into an
aerosol particle collection system, and
the airborne particles produced by the
participant during coughing will be
collected and tested. The sounds
produced during coughing will also be
recorded for analysis and comparison to
the amount of virus expelled. The study
will require 60 volunteer test subjects
each year for 3 years, for a total of 180
test participants.
The following revisions have been
made to the previous approved
information collection request:
(1) Initially, potential participants
will be screened verbally rather than
through the health questionnaire.
(2) The number of potential
participants has been increased from
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hrs.)
Number of
responses per
respondent
Total burden
(in hrs.)
Type of respondents
Form name
Potential participant ..........................
Qualified participant ..........................
Qualified participant ..........................
Initial verbal screening .....................
Informed consent form .....................
Health questionnaire ........................
360
180
180
1
1
1
3/60
15/60
5/60
18
45
15
Total ...........................................
...........................................................
........................
........................
........................
78
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[30-Day–14–13AHA]
Proposed Project
Agency Forms Undergoing Paperwork
Reduction Act Review
[FR Doc. 2013–26787 Filed 11–7–13; 8:45 am]
Centers for Disease Control and
Prevention
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
D.C. 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
World Trade Center Health Program
Enrollment & Appeals—Pentagon &
Shanksville, Pennsylvania
Responders—New—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
TKELLEY on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
VerDate Mar<15>2010
18:08 Nov 07, 2013
Jkt 232001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Background and Brief Description
The James Zadroga 9/11 Health and
Compensation Act of 2010 (Zadroga
Act), promulgated on December 22,
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 78, Number 217 (Friday, November 8, 2013)]
[Notices]
[Pages 67147-67148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26787]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-14-0888]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Kimberly Lane, 1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Persistence of Viable Influenza Virus in Aerosols (0920-0888,
Expiration 05/31/2014)--Revision--National Institute for Occupational
Safety and Health (NIOSH), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Institute for Occupational Safety and Health (NIOSH)
is authorized to conduct research to advance the health and safety of
workers under Section 20(a)(1)
[[Page 67148]]
of the 1970 Occupational Safety and Health Act. Influenza continues to
be a major public health concern because of the substantial health
burden from seasonal influenza and the potential for a severe pandemic.
Although influenza is known to be transmitted by infectious secretions,
these secretions can be transferred from person to person in many
different ways, and the relative importance of the different pathways
is not known. The likelihood of the transmission of influenza virus by
small infectious airborne particles produced during coughing and
breathing is particularly unclear. The question of airborne
transmission is especially important in healthcare facilities, where
influenza patients tend to congregate during influenza season, because
it directly impacts the infection control and personal protective
measures that should be taken by healthcare workers. The purpose of
this study is to measure the amount of viable influenza virus in
airborne particles that are produced by patients when they cough, and
the size and quantity of the particles carrying the virus. A better
understanding of the amount of potentially infectious material released
by patients and the size of the particles carrying the virus will
assist in determining the possible role of airborne transmission in the
spread of influenza and in devising measures to prevent it.
Volunteer adult participants will be recruited by a test
coordinator using a poster and flyers describing the study. Interested
potential participants will be screened verbally to verify that they
have influenza-like symptoms and that they do not have any medical
conditions that would preclude their participation. Qualified
participants who agree to participate in the study will be asked to
read and sign an informed consent form, and then to complete a short
health questionnaire. After completing the forms, two nasopharyngeal
swabs and one oropharyngeal swab will be collected from the
participant. They then will be asked to cough repeatedly into an
aerosol particle collection system, and the airborne particles produced
by the participant during coughing will be collected and tested. The
sounds produced during coughing will also be recorded for analysis and
comparison to the amount of virus expelled. The study will require 60
volunteer test subjects each year for 3 years, for a total of 180 test
participants.
The following revisions have been made to the previous approved
information collection request:
(1) Initially, potential participants will be screened verbally
rather than through the health questionnaire.
(2) The number of potential participants has been increased from
132 to 360. In a previous similar study, the number of potential
participants who agree to join the study was 50%, which was lower than
anticipated. The increase will allow the study to recruit 180
participants.
(3) The number of qualified participants has been increased from
120 to 180. This is necessary to provide a sufficient number of cough
aerosol samples with detectable amounts of viable influenza and is
based on a previous study, where 10% of aerosol samples had culturable
virus.
(4) The Informed consent form has been substantially revised to
make it easier to read and understand. As a result of the revisions,
the burden per response for that form has been reduced from 20 to 15
minutes.
(5) Because of the increases in the number of potential and
qualified participants, the total burden hours has increased from 51 to
78 hours.
(6) The title of the ICR has been changed to ``Factors Influencing
the Transmission of Influenza'' in order to reflect the new focus of
the project on influenza viability and to match the title of the human
subjects protocol approved by the Institutional Review Board.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Potential participant......... Initial verbal 360 1 3/60 18
screening.
Qualified participant......... Informed consent 180 1 15/60 45
form.
Qualified participant......... Health 180 1 5/60 15
questionnaire.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 78
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-26787 Filed 11-7-13; 8:45 am]
BILLING CODE 4163-18-P
